Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
safety profile
Biotech
Sanofi looks for a 'safe' bet in $2.5B tie up for Adagene tech
Sanofi is making a "safe" bet with antibody producer Adagene for up to four cancer candidates in a deal that could reach $2.5 billion in milestones.
Max Bayer
Mar 2, 2022 6:00am
FDA tightens regulations for surgical staplers and staples
Oct 7, 2021 4:55pm
Up-and-coming JAK inhibitors face 'shrinking' potential
Sep 7, 2021 9:30am
Legal cases against Bayer drive surge in Essure safety reports
Mar 8, 2018 9:34am
Elligo to test FDA’s data model for immunotherapy assessment
Oct 11, 2017 11:01am
Roche gets priority review for hyped hemophilia A prospect
Aug 24, 2017 7:40am
